Moderna seeks regulatory approval for its COVID-19 vaccine
The Hindu
Mumbai-based pharmaceutical firm Cipla, on behalf of the U.S. pharma major, has requested for import and marketing authorisation of these jabs
India’s drug regulator may soon grant restricted emergency use authorisation for Moderna’s COVID-19 vaccine, official sources said on June 29. Moderna has also informed that the U.S. Government has agreed to donate a certain number of doses of the Moderna COVID-19 vaccine through COVAX to the Government of India for use and has sought approval from the Central Drugs Standard Control Organisation (CDSCO) for these vaccines. Mumbai-based pharmaceutical firm Cipla, on behalf of the U.S. pharma major, has requested for import and marketing authorisation of these jabs.More Related News

Scaling Artificial Intelligence(AI) at the speed at which consultants project is not possible by the laws of physics and may not be environmentally sustainable, said Tanvir Khan, who is the Executive Vice President and Chief Operating Officer of NTT DATA North America, part of the Japanese technology services and data centre company NTT Data, in an interview with The Hindu.












